Alzheimer’s, amyloid and abandoned antibodies By / On June 29, 2022 / At 1:00 pm / In Chemical world 9 Views Biogen’s aducanumab is stumbling into obscurity. Where does that leave the amyloid hypothesis? Post navigation Prev PostTiny orbitals paint intuitive picture of large molecules’ reactivity Next PostAcoustic analysis is music to mechanochemical ears You May Also Like A custom ink stores data in stable polymers On August 14, 2022 | In Chemical world Recycled beer and ancient wine On August 14, 2022 | In Chemical world Patent inventors must be human, a US federal court rules On August 14, 2022 | In Chemical world